Mirati Therapeutics
MRTX
$58.70
Share price
0.00%
Change (1 day)
29.75%
Change (1 year)
Categories
EPS for Mirati Therapeutics (MRTX)
EPS in 2023 (TTM): -$12.82
According to Mirati Therapeutics's latest financial reports the company's current EPS (TTM) is -$12.82. In 2022 the company made an earnings per share (EPS) of -$13.18 a decrease over its 2021 EPS that were of -$11.17.
EPS history for Mirati Therapeutics from 2005 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$12.82 | -2.73% |
| 2022 | -$13.18 | 17.99% |
| 2021 | -$11.17 | 40.5% |
| 2020 | -$7.95 | 40.96% |
| 2019 | -$5.64 | 77.92% |
| 2018 | -$3.17 | 13.62% |
| 2017 | -$2.79 | -33.57% |
| 2016 | -$4.20 | 10.82% |
| 2015 | -$3.79 | 16.98% |
| 2014 | -$3.24 | -32.19% |
| 2013 | -$4.78 | 68.77% |
| 2012 | -$2.83 | -15.95% |
| 2011 | -$3.37 | -81.27% |
| 2010 | -$17.98 | -37.19% |
| 2009 | -$28.63 | 174.53% |
| 2008 | -$10.43 | -65.27% |
| 2007 | -$30.02 | 146.72% |
| 2006 | -$12.17 | -58.81% |
| 2005 | -$29.55 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 TravelCenters of America TA | $9.52 | -174.26% | 🇺🇸 USA |
 Nymox Pharmaceutical NYMX | -$0.06000 | -99.53% | Bahamas |